Breaking News

Fuji Chemical Granted Inflammation Patent

September 8, 2006

Patent No. US 7,078,040 B2: Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ has been granted a patent for inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin. Fuji’s pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia.

blog comments powered by Disqus
  • Innovation On Display

    Melissa Meisel, Associate Editor||February 3, 2016
    P&G Beauty Digital Studio showcases new products for 2016

  • Crowning Glory

    Crowning Glory

    Christine Esposito , Associate Editor||February 3, 2016
    Celebrity stylists and experts from leading hair care brands talk about the ingredients and formats driving the styling sector.

  • Electric Slide

    Electric Slide

    Melissa Meisel, Associate Editor||February 3, 2016
    Skin care devices bring anti-aging to the next level